Article
KRAS and NRAS mutational analysis in plasma ctDNA from patients with metastatic colorectal cancer by real-time PCR and digital PCR.
International journal of colorectal disease - 1 Apr 2022
Pinheiro Manuela, Peixoto Ana, Rocha Patricia, Veiga Isabel, Pinto Carla, Santos Catarina, Pinto Pedro, Guerra Joana, Escudeiro Carla, Barbosa Ana, Silva João, Teixeira Manuel R
Abstract excerpt
PURPOSE: Mutations in the KRAS and NRAS (RAS) genes are negative predictors of response to anti-EGFR therapy in metastatic colorectal cancer (mCRC). The detection of mutations in circulating tumor DNA (ctDNA) has emerged as a less invasive strategy to assess the molecular profile of mCRC patients. We aimed to perform RAS mutational analysis in ctDNA from mCRC patients using BEAMing Digital PCR (OncoBEAM) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
